Visa enkel post

dc.contributor.authorHolmgren, Christina
dc.date.accessioned2011-11-25T13:28:43Z
dc.date.available2011-11-25T13:28:43Z
dc.date.issued2011-11-25
dc.identifier.isbnISBN 978-91-628-8389-8
dc.identifier.urihttp://hdl.handle.net/2077/25495
dc.description.abstractOn the causes of ventricular arrhythmia, its treatment and outcome Christina Holmgren Institute of Medicine Sahlgrenska Academy at University of Gothenburg Göteborg, Sweden ABSTRACT Background: Ventricular arrhythmia is the most common aetiology of sudden cardiac death. Death can sometimes be prevented by the implantation of a defibrillator (ICD). When an out-of-hospital cardiac arrest (OHCA) has occurred some circumstances characterize those who survive. Medication used to treat disease is not always harmless. Methods: The population in the Swedish Cardiac Arrest Register was used to characterize the survivors, and for the recently added drugs, before an OHCA, used together with the Swedish Prescribed Drug Register. The outcome of all consecutive acute myocardial infarction patients during 21 month time at Sahlgrenska University Hospital was investigated to determine if a simple echocardiographic criterion could identify the patients that would die of arrhythmia during two years after the myocardial infarction. Thirty patients with an implanted defibrillator were tested with Transcutaneous Electrical Nerve Stimulation (TENS) to determine the risk of electrical interference with the ICD. Results: The echocardiographic criterion of an ejection fraction ≤30% alone, found only three of the patients who died of presumed arrhythmia and only one of them would have been implanted with an ICD in clinical practice. Six patients who died of presumed arrhythmia had a better ejection fraction. The TENS interfered with 16/30 ICDs. Among survivors of OHCA 20% were from the group found in a non-shockable rhythm and the majority was not reached by the ambulance within five minutes. Recently added drugs before OHCA were most often prescribed for infectious, respiratory and neuro-psychological diseases. 16.2% of the OCHA victims had recently claimed a drug from the” qtdrugs.org” lists .Conclusion: Better criteria or combinations are needed to identify the patients that would benefit from an ICD on a primary prevention indication after myocardial infarction. The TENS device cannot be recommended to be used simultaneously with an ICD and protocols for testing other implantable devices to be used together with an ICD are warranted. New drugs frequently claimed before OHCA should be further investigated and the OHCA victims found in non-shockable rhythm need more attention. The delay-time for ambulance arrival to the OHCA victim is long. Keywords: Cardiac arrest, ICD, ventricular arrhythmia ISBN: 978-91-628-8389-8sv
dc.language.isoengsv
dc.relation.haspartI. Presumed arrhythmic death in consecutive survivors of acute myocardial infarction--implications for primary implantable cardioverter defibrillator implantation Holmgren CM, Nyström BM, Karlsson TK, Herlitz JD, Edvardsson NG. Coron Artery Dis. 2009 Mar;20(2):155-62 ::PMID::19238081sv
dc.relation.haspartII. Analysis of initial rhythm, witnessed status and delay to treatment among survivors of out-of-hospital cardiac arrest in Sweden Holmgren C, Bergfeldt L, Edvardsson N, Karlsson T, Lindqvist J, Silfverstolpe J, Svensson L, Herlitz J. Heart. 2010 Nov;96(22):1826-30. Epub 2010 Oct 3. ::PMID::20889992sv
dc.relation.haspartIII. Risk of interference from transcutaneous electrical nerve stimulation on the sensing function of implantable defibrillators Holmgren C, Carlsson T, Mannheimer C, Edvardsson N. Pacing Clin Electrophysiol. 2008 Feb;31(2):151-8. ::PMID::18233966sv
dc.relation.haspartIV. Recent changes in medication in out-of-hospital cardiac arrest victims Holmgren C, Abdon NJ, Bergfeldt L, Edvardsson N, Herlitz J, Svensson L, Åstrand B In manuscriptsv
dc.subjectCardiac arrestsv
dc.subjectICDsv
dc.subjectventricular arrhythmiasv
dc.titleOn the causes of ventricular arrhythmia, its treatment and outcomesv
dc.typetexteng
dc.type.svepDoctoral thesiseng
dc.gup.mailc.holmgren@telia.comsv
dc.type.degreeDoctor of Philosophy (Medicine)sv
dc.gup.originUniversity of Gothenburg. Sahlgrenska Academysv
dc.gup.departmentInstitute of Medicine. Department of Molecular and Clinical Medicinesv
dc.gup.defenceplaceFredagen den 16 december 2011, kl. 9.00, Hörsal Hjärtats Aula Sahlgrenska universitetssjukhusetsv
dc.gup.defencedate2011-12-16
dc.gup.dissdb-fakultetSA


Filer under denna titel

Thumbnail
Thumbnail

Dokumentet tillhör följande samling(ar)

Visa enkel post